6 compounds
Growth Factors
Compounds studied for interaction with the somatotropic axis, including growth hormone-releasing hormone receptor agonists, ghrelin receptor secretagogues, and insulin-like growth factor analogues. Endpoints typically include receptor binding, pituitary cell secretion assays, and downstream signalling measurement.
CJC-1295
GHRH analog
A tetrasubstituted analogue of growth hormone-releasing hormone (1-29), studied in pituitary secretion research.
CJC-1295 / Ipamorelin
GH Blend
A prepared blend pairing a GHRH analogue with a selective ghrelin receptor secretagogue.
Tesamorelin
GHRH analog
A stabilised 44-residue GHRH analogue carrying an N-terminal hexenoyl modification.
Sermorelin
GHRH analog
The 29-residue amidated N-terminal fragment of growth hormone-releasing hormone.
Tesamorelin / Ipamorelin
GH Blend
A prepared blend pairing a full-length GHRH analogue with a selective ghrelin receptor secretagogue.
IGF-1 LR3
Insulin-like growth factor-1 LR3
An 83-residue IGF-1 analogue engineered for reduced binding-protein affinity.